Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson's Disease: A Diffusion Tensor Imaging Study

被引:3
|
作者
Bergsland, Niels [1 ,2 ]
Pelizzari, Laura [1 ]
Lagana, Maria Marcella [1 ]
Di Tella, Sonia [1 ]
Rossetto, Federica [1 ]
Nemni, Raffaello [1 ,3 ]
Clerici, Mario [1 ,3 ]
Baglio, Francesca [1 ]
机构
[1] Fdn Don Carlo Gnocchi ONLUS, IRCCS, I-20148 Milan, Italy
[2] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14203 USA
[3] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
来源
JOURNAL OF PERSONALIZED MEDICINE | 2021年 / 11卷 / 11期
关键词
Parkinson's disease; MRI; substantia nigra; diffusion tensor imaging; FREE-WATER; SEGMENTATION; MOVEMENT;
D O I
10.3390/jpm11111235
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The substantia nigra (SN) pars compacta (SNpc) and pars reticulata (SNpr) are differentially affected in Parkinson's disease (PD). Separating the SNpc and SNpr is challenging with standard magnetic resonance imaging (MRI). Diffusion tensor imaging (DTI) allows for the characterization of SN microstructure in a non-invasive manner. In this study, 29 PD patients and 28 healthy controls (HCs) were imaged with 1.5T MRI for DTI. Images were nonlinearly registered to standard space and SNpc and SNpr DTI parameters were measured. ANCOVA and receiver operator characteristic (ROC) analyses were performed. Clinical associations were assessed with Spearman correlations. Multiple corrections were controlled for false discovery rate. PD patients presented with significantly increased SNpc axial diffusivity (AD) (1.207 & PLUSMN; 0.068 versus 1.156 & PLUSMN; 0.045, p = 0.024), with ROC analysis yielding an under the curve of 0.736. Trends with Unified Parkinson's Disease Rating Scale (UPDRS) III scores were identified for SNpc MD (rs = 0.449), AD (rs = 0.388), and radial diffusivity (rs = 0.391) (all p < 0.1). A trend between baseline SNpr MD and H & Y change (rs = 0.563, p = 0.081) over 2.9 years of follow-up was identified (n = 14). In conclusion, SN microstructure shows robust, clinically meaningful associations in PD.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Downregulation of thioredoxin reductase 1 expression in the substantia nigra pars compacta of Parkinson's disease mice
    Liu, Zihua
    Jing, Yuhong
    Yin, Jie
    Mu, Jiying
    Yao, Tingting
    Gao, Liping
    NEURAL REGENERATION RESEARCH, 2013, 8 (35) : 3275 - 3283
  • [12] Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease
    McNaught, KSP
    Belizaire, R
    Jenner, P
    Olanow, CW
    Isacson, O
    NEUROSCIENCE LETTERS, 2002, 326 (03) : 155 - 158
  • [13] Combined R2*and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease
    Du, Guangwei
    Lewis, Mechelle M.
    Styner, Martin
    Shaffer, Michele L.
    Sen, Suman
    Yang, Qing X.
    Huang, Xuemei
    MOVEMENT DISORDERS, 2011, 26 (09) : 1627 - 1632
  • [14] Olfactory Testing and Diffusion Tensor Imaging of Olfactory Tract and Substantia Nigra in Early Parkinson's Disease
    Robertson, H. A.
    Rolheiser, T. M.
    Fulton, H.
    Good, K. P.
    Leslie, R. A.
    Fisk, J. D.
    McKelvey, J. R.
    Schoffer, K.
    Khan, N. M.
    Scherfler, C.
    MOVEMENT DISORDERS, 2010, 25 : S663 - S663
  • [15] Diffusion tensor imaging of the substantia nigra as a biomarker for REM sleep behavior disorder and Parkinson's disease
    Brodsky, M. A.
    Grinstead, J.
    Lahna, D.
    Pollock, J.
    Brodsky, M.
    MOVEMENT DISORDERS, 2014, 29 : S67 - S67
  • [16] The Lesion of the Rat Substantia Nigra pars compacta Dopaminergic Neurons as a Model for Parkinson's Disease Memory Disabilities
    Claudio Da Cunha
    Miriam Elizabeth Mendes Angelucci
    Newton S. Canteras
    Susan Wonnacott
    Reinaldo N. Takahashi
    Cellular and Molecular Neurobiology, 2002, 22 : 227 - 237
  • [17] Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?
    Xu, Huadong
    Cheng, Xu
    Song, Qian
    Yang, Yuxin
    Wang, Changhe
    Kang, Xinjiang
    NEUROSCIENCE BULLETIN, 2022, 38 (7) : 820 - 824
  • [18] Induced Dopaminergic Neurons for Parkinson’s Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?
    Huadong Xu
    Xu Cheng
    Qian Song
    Yuxin Yang
    Changhe Wang
    Xinjiang Kang
    Neuroscience Bulletin, 2022, 38 : 820 - 824
  • [19] The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities
    Da Cunha, C
    Angelucci, MEM
    Canteras, NS
    Wonnacott, S
    Takahashi, RN
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2002, 22 (03) : 227 - 237
  • [20] Substantia nigra pars reticulata neurons in Parkinson's disease
    Hardman, CD
    McRitchie, DA
    Halliday, GM
    Cartwright, HR
    Morris, JGL
    NEURODEGENERATION, 1996, 5 (01): : 49 - 55